You are here

Aromasin

ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

Yahoo/Benzinga

Thu, 06/5/14 - 09:14 am

DARA Biosciences

Bristol-Myers Squibb

Afinitor data could be 'game-changer' in breast cancer

Fierce Pharma

Mon, 09/26/11 - 12:05 pm

mTOR inhibitors

Pfizer’s Aromasin Blocks Breast Cancer in Healthy, At-Risk Women in Study

Bloomberg

Sun, 06/5/11 - 10:32 am

Pfizer, Novartis, AstraZeneca Cancer Drugs Increase Heart Risks

Bloomberg

Thu, 12/9/10 - 12:08 pm